Longevity Acquisition (LOACU) Stock Price, News & Analysis

Company Overview

Longevity Acquisition Corp (OTCMKTS: LOACU) is a special purpose acquisition company (SPAC) formed to identify, acquire, and merge with private businesses operating in the life sciences and healthcare sectors. Established in Delaware in 2021, the company raised capital through its initial public offering with the specific mandate of targeting enterprises that develop innovative therapies, diagnostics, and digital health solutions aimed at extending human healthspan and addressing age-related diseases.

The company focuses on businesses involved in biotechnology, medical devices, precision diagnostics, and digital health platforms. Its investment thesis centers on companies that leverage cutting-edge research and development—such as gene editing, regenerative medicine, and AI-driven drug discovery—to create differentiated products and services for aging populations. By combining public capital with deep industry expertise, Longevity Acquisition seeks to accelerate commercialization trajectories and support portfolio companies through clinical development and regulatory processes.

Since its formation, Longevity Acquisition has evaluated opportunities across North America, Europe, and select Asian markets, reflecting a global approach to healthcare innovation. The company’s management team brings together professionals with experience in biomedical research, investment banking, and regulatory affairs. Its leadership comprises Chief Executive Officer David A. Roberts, a former biotech equity analyst with over 15 years in healthcare finance, and Chief Financial Officer Maria Chen, who previously held senior roles in corporate treasury for public pharmaceutical firms.

With a dedicated advisory board that includes academic researchers and industry veterans, Longevity Acquisition aims to leverage strategic partnerships and operational guidance to support its target companies. The SPAC structure provides a streamlined pathway for private firms to access public markets, while the team’s sector expertise is designed to foster sustainable growth and drive long-term value creation for shareholders and stakeholders in the evolving longevity ecosystem.

Key Stats

• Today's Range: $14.99 to $14.99
• 50-Day Range: $14.99 to $14.99
• 52-Week Range: $11.10 to $20.50
• Volume: N/A
• Average Volume: 440 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LOACU Stock Analysis - Frequently Asked Questions

How have LOACU shares performed this year?

Longevity Acquisition's stock was trading at $14.99 at the beginning of 2025. Since then, LOACU shares have increased by 0.0% and is now trading at $14.99.

How do I buy shares of Longevity Acquisition?

Shares of LOACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Finance
• Industry: Conglomerates
• Sub-Industry: Trading
• Current Symbol: OTCMKTS:LOACU
• CIK: N/A
• Web: N/A
• Phone: 86 21 6083 2028
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A